Abstract :

Background:  The human stomach is colonized by Helicobacter pylori (H. pylori), a Gram-negative bacterium. A chronic H. pylori infection can lead to a number of gastrointestinal disorders, including gastric cancer.

Objective: The study aimed to investigate serum level IL6, IL1β, and TNF-a with iron status to assess the severity of infection.

Methods: Case control study design involved 100 participants (50 patients and 50 control), for each groups, rapid H. pylori stool antigen test, IgG, serum IL6, IL1β, and serum TNF-α were estimated along with iron parameters.

Results:  Immunological marker concentrations in the patient and control groups. All tested indices, comprising IgG, IL-6, IL-1β, and TNF-α, showed statistically notable increase in comparison with control (p< 0.001). Parameters related to iron were highly skewed such as serum iron, ferritin, total iron binding capacity (TIBC), serum iron, and transferrin value (p < 0.001).

Conclusion:  These indicators can be used to diagnose and/or monitor the course of an infection since H. pylori infection can drastically affect the diagnostic indicators and the markers typically used to measure the degree of inflammation during infection.

---

Keywords :

H. pylori., IgG, IL1B, IL6, TNF-a

---

References :

1. Espinoza-Contreras GJ, Torres-Ruiz MI, Waller-González LA, Ramírez-García DJ, Torres-López J, Ventura-Juárez J, et al. Immunological markers and Helicobacter pylori in patients with stomach cancer: expression and correlation. Biomed Rep. 2020;12(5):233-243. doi:10.3892/br.2020.1276. Available from: https://www.spandidos-publications.com/10.3892/br.2020.1276.
2. Li T, Shao W, Li S, Ma L, Zheng L, Shang W, et al. Helicobacter pylori infection induced BMAL1 expression and rhythm disorder aggravate gastric inflammation. EBioMedicine. 2019;39:301-314. doi:10.1016/j.ebiom.2018.12.030. Available from: https://www.sciencedirect.com/journal/ebiomedicine.
3. Chen HY, Hu Y, Lu NH, Zhu Y. Caudal type homeoboxes as a driving force in Helicobacter pylori infection-induced gastric intestinal metaplasia. Gut Microbes. 2020;12(1):1809331. doi:10.1080/19490976.2020.1809331. Available from: https://www.tandfonline.com.
4. Zhang X, He Y, Zhang X, Fu B, Song Z, Wang L, et al. Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6. Gastric Cancer. 2024;27(2):324-342. doi:10.1007/s10120-023-01415-5. Available from: https://link.springer.com.
5. Nguyen TC, Tang NLC, Le GKN, Nguyen VT, Nguyen KHG, Che TH, et al. Helicobacter pylori infection and peptic ulcer disease in symptomatic children in southern Vietnam: a prospective multicenter study. Healthcare. 2023;11(11):1658. doi:10.3390/healthcare11111658. Available from: https://www.mdpi.com.
6. Güzel M, Sönmez MF, Baştuğ O, Aras NF, Öztürk AB, Küçükaydın M, et al. Effectiveness of lycopene on experimental testicular torsion. J Pediatr Surg. 2016;51(7):1187-1191. doi:10.1016/j.jpedsurg.2015.12.019. Available from: https://www.journals.elsevier.com
7. Yang H, Hu B. Immunological perspective: Helicobacter pylori infection and gastritis. Mediators Inflamm. 2022;2022:2944156. doi:10.1155/2022/2944156. Available from: https://www.hindawi.com
8. Keikha M, Ali-Hassanzadeh M, Karbalaei M. Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):266. doi:10.1186/s12876-020-01388-7. Available from: https://bmcgastroenterol.biomedcentral.com.
9. Shakhatreh MAK, Khabour OF, Alzoubi KH, BaniHani MN, Abu-Siniyeh A, Bashir NA, et al. The influence of IL-1B gene polymorphisms on Helicobacter pylori infection and triple treatment response among Jordanian population. Appl Clin Genet. 2020;13:139-145. doi:10.2147/TACG.S242383. Available from: https://www.dovepress.com.
10. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. Helicobacter pylori infection and gastric cancer: state of the art. Int J Oncol. 2013;42(1):5-18. doi:10.3892/ijo.2012.1701. Available from: https://www.spandidos-publications.com.
11. Castillo-Montoya V, Ruiz-Bustos E, Valencia-Juillerat ME, Álvarez-Hernández G, Sotelo-Cruz N. Detection of Helicobacter pylori in children and adolescents using the monoclonal coproantigen immunoassay and its association with gastrointestinal diseases. Cir Cir. 2017;85(1):27-33. doi:10.1016/j.circir.2016.06.010. Available from: https://www.elsevier.es.
12. Khoder G, Mina S, Mahmoud I, Muhammad JS, Harati R, Burucoa C. Helicobacter pylori infection in Tripoli, North Lebanon: assessment and risk factors. Biology. 2021;10(7):599. doi:10.3390/biology10070599. Available from: https://www.mdpi.com.
13. Mohammadzadeh R, Menbari S, Pishdadian A, Farsiani H. Helicobacter pylori virulence factors: subversion of host immune system and development of various clinical outcomes. Expert Rev Mol Med. 2023;25:e23. doi:10.1017/erm.2023.12. Available from: https://www.cambridge.org.
14. Kasmi H, Doukani K, Ali A, Tabak S, Bouhenni H. Epidemiological profile of Helicobacter pylori infection in patients with digestive symptoms in Algeria. J Epidemiol Glob Health. 2020;10(4):293-297. doi:10.2991/jegh.k.200909.001. Available from: https://link.springer.com.
15. Miguel N. Hematological extradigestive manifestations of Helicobacter pylori infection in childhood. In: Extradigestive Manifestations of Helicobacter pylori Infection—An Overview. 2016. Available from: https://www.intechopen.com.
16. Mwafy SN, Afana WM. Hematological parameters, serum iron and vitamin B12 levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: a case-control study. Hematol Transfus Cell Ther. 2018;40(2):160-165. doi:10.1016/j.htct.2017.08.001. Available from: https://www.scielo.br.
17. Rahman YA, Ahmed LAW, Hafez RMM, Ahmed RMM. Helicobacter pylori and its hematological effect. Egypt J Intern Med. 2019;31(3):332-342. doi:10.4103/ejim.ejim_10_19. Available from: https://ejim.springeropen.com.
18. Yaqoob QA, Mahdi HA, Farman HA, Sasaa MA. Association of chronic Helicobacter pylori infection with iron deficiency anemia. Ann Rom Soc Cell Biol. 2021;25(6):1554-1560. Available from: http://annalsofrscb.ro.
19. Haile K, Timerga A. Evaluation of hematological parameters of Helicobacter pylori-infected adult patients at Southern Ethiopia: a comparative cross-sectional study. J Blood Med. 2021;12:77-84. doi:10.2147/JBM.S287043. Available from: https://www.dovepress.com.
20. Smirnova OV, Sinyakov AA, Kasparov EV. The role of immunoglobulin G, IgA and IgE antibodies against Helicobacter pylori in the development of oxidative stress in patients with chronic gastritis. Biomedicines. 2022;10(8):2053. doi:10.3390/biomedicines10082053. Available from: https://www.mdpi.com.
21. Milic L, Karamarkovic A, Popadic D, Sijacki A, Grigorov I, Milosevic E, et al. Altered cytokine expression in Helicobacter pylori infected patients with bleeding duodenal ulcer. BMC Res Notes. 2019;12:278. doi:10.1186/s13104-019-4308-6. Available from: https://bmcresnotes.biomedcentral.com.
22. Ali MR. Correlation between Helicobacter pylori infection and the level of serum inflammatory markers. Iraqi J Med Sci. 2024;22(2). Available from: (journal website).

23. Al-Karawi AS, Rasool KH, Atoom AM, Kadhim AS. Correlation between Helicobacter pylori infection and serum levels of inflammatory markers: a retrospective study. Al-Salam J Med Sci. 2023;2(2):20-24. Available from: (journal platform).
24. Rébé C, Ghiringhelli F. Interleukin-1β and cancer. Cancers. 2020;12(7):1791. doi:10.3390/cancers12071791. Available from: https://www.mdpi.com.
25. Filaly HE, Outlioua A, Medyouf H, Guessous F, Akarid K. Targeting IL-1β in patients with advanced Helicobacter pylori infection: a potential therapy for gastric cancer. Future Microbiol. 2022;17(8):633-641. doi:10.2217/fmb-2021-0193. Available from: https://www.futuremedicine.com.